PresentationVirtual mode
The appearance of COVID - 19 and its rapid expansion worldwide has conditioned a radical change at all levels, but this change has been much more drastic and dramatic in all aspects related to health care, establishing a change in paradigms. that over the last centuries we had learned and used for the interrelation with the patient, the formation of future healthcare professionals and the resources derived from translational research.
This radical change has established an impact at the social level, making global care for patients affected by this disease the main priority in most countries, regardless of their location, social, political or economic structure. But in addition, and with the passage of time, we are being able to verify the enormous effect that social and interaction norms establish on the development of this disease, which has conditioned that many prestigious authors begin to speak of a syndemic instead of a pandemic.
At the present time, there is a clear demand on the part of our society so that among all of us, we are able firstly to put a stop to this disease and secondly to establish the bases for its definitive control and this demand is increasingly evident as a consequence of the enormous impact that it is producing at all levels, even changing the rules of daily coexistence that we had known and used for centuries.
From a purely health point of view, in December 2019 the transmission of a new pneumonia-producing coronavirus was detected in Wuhan (China), which was identified by gene sequencing analysis through samples from the lower respiratory tract. It was decided to name the infective agent type 2 coronavirus (SARS-CoV-2) and the disease produced by it as COVID-19.
Given the existing ignorance in the face of the rapid expansion of the agent and the absence of scientific evidence of sufficient robustness to have a standardized treatment, multiple therapeutic resources have been used to control one of the main problems expressed within this disease, such as severe acute respiratory failure, not currently having an action plan with sufficient scientific support to allow homogeneity from the therapeutic point of view.
For all the above, it is urgent to have regulated and standardized training actions that are capable of laying the foundations of clinical, diagnostic, therapeutic and prognostic action in this very particular type of patients affected by an emerging disease with an enormous capacity to generate situations consistent with multi-organ dysfunction and a high mortality and morbidity rate.
Finally, and when treating a disease that as such did not exist a year ago, the necessary training to cope is not regulated. It is not taught in medical schools, there are no specific postgraduate courses for the management of this pathology and specialists are orphans of specific and regulated training programs that can facilitate and standardize their professional development.
Everything expressed above highlights the importance of the generation of a specific doctrinal body that supports from the best available scientific evidence the actions to be carried out at the care, teaching, research and planning level to respond to what is currently considered as the largest pandemic in human history.